Based on data from the past 90 days ending February 19, 2026, Allarity Therapeutics's three largest insider shareholders are Ceo Thomas Jensen (396.73K shares), Officer Jeremy R. Graff (381.64K shares), Cfo Alexander Epshinsky (85.05K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Thomas Jensen | Ceo | 396,734 | 24 Jan, 2025 |
| Jeremy R. Graff | Nan | 381,644 | 16 Jan, 2026 |
| Alexander Epshinsky | Cfo | 85,051 | 24 Jan, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 07 Jan, 2026 | Jeremy R. Graff | Common Stock | A | 133,333 | $0.00 | 381,644 | D | A |
| 30 Sep, 2025 | Jeremy R. Graff | Common Stock | A | 39,494 | - | 39,494 | D | M |
| 30 Sep, 2025 | Jeremy R. Graff | Common Stock | D | 14,613 | $1.58 | 24,881 | D | F |
| 22 Jan, 2025 | Thomas Jensen | Common Stock | A | 396,734 | $0.00 | 396,734 | D | A |
| 22 Jan, 2025 | Jeremy R. Graff | Common Stock | A | 144,441 | $0.00 | 262,924 | D | A |
| 22 Jan, 2025 | Alexander Epshinsky | - | - | 85,051 | D | |||
| 22 Jan, 2025 | Alexander Epshinsky | Common Stock | A | 29,496 | $0.00 | 85,051 | D | A |
| 30 Sep, 2024 | Jeremy R. Graff | Common Stock | A | 118,483 | $2.11 | 118,483 | D | A |